David Fernandez-Antoran

David Fernandez-Antoran

Auto-generated profile, based on publicly available information

David Fernandez-Antoran

University of Cambridge

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Nature
Verified
Journal Article
Closed access
PDF file
BCB. Colom
B. Colom
AHA. Herms
A. Herms
MHM. W. J. Hall
M. W. J. Hall
SDS. C. Dentro
S. C. Dentro
CKC. King
C. King
PJP. H. Jones
P. H. Jones

1 September 2019 in Cell Stem Cell
Verified
Journal Article
Open access
DFDavid Fernandez-Antoran
David Fernandez-Antoran
GPGabriel Piedrafita
Gabriel Piedrafita
KMKasumi Murai
Kasumi Murai
SOSwee Hoe Ong
Swee Hoe Ong
AHAlbert Herms
Albert Herms
PJPhilip H. Jones
Philip H. Jones
As humans age, normal tissues, such as the esophageal epithelium, become a patchwork of mutant clones. Some mutations are under positive selection, conferring a competitive advantage over wild-type cells. We speculated that altering the selective pressure on mutant cell populations may cause them to expand or contract. We tested this hypothesis by examining the effect of oxidative stress from low-dose ionizing radiation (LDIR) on wild-type and p53 mutant cells in the transgenic mouse esophagus. We found that LDIR drives wild-type cells to stop proliferating and differentiate. p53 mutant cells are insensitive to LDIR and outcompete wild-type cells following exposure. Remarkably, combining antioxidant treatment and LDIR reverses this effect, promoting wild-type cell proliferation and p53 mutant differentiation, reducing the p53 mutant population. Thus, p53-mutant cells can be depleted from the normal esophagus by redox manipulation, showing that external interventions may be used to alter the mutational landscape of an aging tissue.

1 February 2021 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
JFJoanna C. Fowler
Joanna C. Fowler
CKCharlotte King
Charlotte King
CBChristopher Bryant
Christopher Bryant
MHMichael W.J. Hall
Michael W.J. Hall
RSRoshan Sood
Roshan Sood
PJPhilip H. Jones
Philip H. Jones
Skin cancer risk varies substantially across the body, yet how this relates to the mutations found in normal skin is unknown. Here we mapped mutant clones in skin from high- and low-risk sites. The density of mutations varied by location. The prevalence of NOTCH1 and FAT1 mutations in forearm, trunk, and leg skin was similar to that in keratinocyte cancers. Most mutations were caused by ultraviolet light, but mutational signature analysis suggested differences in DNA-repair processes between sites. Eleven mutant genes were under positive selection, with TP53 preferentially selected in the head and FAT1 in the leg. Fine-scale mapping revealed 10% of clones had copy-number alterations. Analysis of hair follicles showed mutations in the upper follicle resembled adjacent skin, but the lower follicle was sparsely mutated. Normal skin is a dense patchwork of mutant clones arising from competitive selection that varies by location. Significance: Mapping mutant clones across the body reveals normal skin is a dense patchwork of mutant cells. The variation in cancer risk between sites substantially exceeds that in mutant clone density. More generally, mutant genes cannot be assigned as cancer drivers until their prevalence in normal tissue is known. See related commentary by De Dominici and DeGregori, p. 227. This article is highlighted in the In This Issue feature, p. 211

18 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
GPGabriel Piedrafita
Gabriel Piedrafita
VKVasiliki Kostiou
Vasiliki Kostiou
AWAgnieszka Wabik
Agnieszka Wabik
BCBartomeu Colom
Bartomeu Colom
DFDavid Fernandez-Antoran
David Fernandez-Antoran
PJPhilip H. Jones
Philip H. Jones
In adult skin epidermis and the epithelium lining the esophagus cells are constantly shed from the tissue surface and replaced by cell division. Tracking genetically labelled cells in transgenic mice has given insight into cell behavior, but conflicting models appear consistent with the results. Here, we use an additional transgenic assay to follow cell division in mouse esophagus and the epidermis at multiple body sites. We find that proliferating cells divide at a similar rate, and place bounds on the distribution cell cycle times. By including these results in a common analytic approach, we show that data from eight lineage tracing experiments is consistent with tissue maintenance by a single population of proliferating cells. The outcome of a given cell division is unpredictable but, on average, the likelihood of producing proliferating and differentiating cells is equal, ensuring cellular homeostasis. These findings are key to understanding squamous epithelial homeostasis and carcinogenesis.

15 June 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MVMireia Vallespinós
Mireia Vallespinós
DFDavid Fernández
David Fernández
LRLorena Rodríguez
Lorena Rodríguez
JAJosué Alvaro-Blanco
Josué Alvaro-Blanco
EBEsther Baena
Esther Baena
IAIgnacio Moreno de Alborán
Ignacio Moreno de Alborán
C-Myc, a member of the Myc family of transcription factors, is involved in numerous biological functions including the regulation of cell proliferation, differentiation, and apoptosis in various cell types. Of all of its functions, the role of c-Myc in cell differentiation is one of the least understood. We addressed the role of c-Myc in B lymphocyte differentiation. We found that c-Myc is essential from early stages of B lymphocyte differentiation in vivo and regulates this process by providing B cell identity via direct transcriptional regulation of the ebf-1 gene. Our data show that c-Myc influences early B lymphocyte differentiation by promoting activation of B cell identity genes, thus linking this transcription factor to the EBF-1/Pax-5 pathway.

21 August 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
AHAlbert Herms
Albert Herms
BCBartomeu Colom
Bartomeu Colom
GPGabriel Piedrafita
Gabriel Piedrafita
AKArgyro Kalogeropoulou
Argyro Kalogeropoulou
UBUjjwal Banerjee
Ujjwal Banerjee
PJPhilip H. Jones
Philip H. Jones
Oncogenic PIK3CA mutations generate large clones in aging human esophagus. Here we investigate the behavior of Pik3ca mutant clones in the normal esophageal epithelium of transgenic mice. Expression of a heterozygous Pik3caH1047R mutation drives clonal expansion by tilting cell fate toward proliferation. CRISPR screening and inhibitor treatment of primary esophageal keratinocytes confirmed the PI3K–mTOR pathway increased mutant cell competitive fitness. The antidiabetic drug metformin reduced mutant cell advantage in vivo and in vitro. Conversely, metabolic conditions such as type 1 diabetes or diet-induced obesity enhanced the competitive fitness of Pik3caH1047R cells. Consistently, we found a higher density of PIK3CA gain-of-function mutations in the esophagus of individuals with high body mass index compared with those with normal weight. We conclude that the metabolic environment selectively influences the evolution of the normal epithelial mutational landscape. Clinically feasible interventions to even out signaling imbalances between wild-type and mutant cells may limit the expansion of oncogenic mutants in normal tissues.